C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ): measurement properties and estimated clinically meaningful thresholds from a phase 3 study” was published online by JTO Clinical and Research Reports on February 16, 2022. The article reports findings from analyses that used clinical trial data to evaluate the NSCLC-SAQ’s longitudinal measurement properties and is the first publication to present estimates of clinically meaningful within-person change for the NSCLC-SAQ.
Access here: https://doi.org/10.1016/j.jtocrr.2022.100298
